Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels

Human antibodies to the human glucagon receptor and methods of use thereof to lower blood glucose or ketone levels

US Patent 11498970 · Granted Nov 15, 2022

Estimated economic value: $208,367,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Binding proteins to the human thrombin receptor, PAR42025
Polynucleotides encoding anti-glucagon-like peptide 1 receptor (GLP1R) antagonis2025
Antibody-drug conjugates comprising GLP1 peptidomimetics and uses thereof2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Human antibodies to the human glucagon receptor (HGCGR) and methods of use there2025
Anti-PCSK9 antibodies2025
Genetically modified mouse with a humanized PNPLA3 gene and methods of use2025
Methods of treating urea cycle disorders by interfering with glucagon receptor s2024
Glucagon-like peptide 1 receptor agonists and uses thereof2024
Substrate for a printed wiring board2024
Antibodies which bind to glucagon-like peptide 1 receptor (GLP1R)2024